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Abstract Small colony variants of Staphylococcus au-
reus can cause persistent and recurrent infections. There
are only a few reports of small colony variants of
coagulase-negative staphylococci. Herein a case of
infection with a teicoplanin-resistant small colony variant
of Staphylococcus epidermidis is presented. The small
colony variant was isolated from blood cultures of a
patient with acute leukaemia and therapy-induced neu-
tropenia who was treated with vancomycin for catheter-
associated bloodstream infection. Despite removal of the
catheter and adequate antibiotic therapy, the infection did
not clear and the patient died 20 days after continuous
antibiotic therapy.
Introduction
Small colony variants (SCVs) of Staphylococcus aureus
have been found in a variety of clinical specimens and
have been associated with persistent and recurrent
infections [1, 2, 3]. Only a few cases of infection with
SCVs of coagulase-negative staphylococci (CoNS) have
been reported. SCVs of Staphylococcus epidermidis have
been linked to prosthetic heart valve endocarditis and
infection of pacemaker electrodes [4, 5]. Bloodstream
infection caused by Staphylococcus epidermidis and
Staphylococcus capitis following pacemaker implantation
has also been reported [6]. Here we describe a te-
icoplanin-resistant SCV of Staphylococcus epidermidis
which emerged during vancomycin therapy of a catheter-
associated bloodstream infection in a neutropenic patient.
Case Report
A 69-year-old patient was admitted to hospital for treatment of
acute myeloid leukaemia. He was treated with high-dose chemo-
therapy and became neutropenic and febrile. Despite broad-
spectrum antibiotic and amphotericin B therapy, the fever persisted.
Between day 5 and day 16 of hospitalisation 15 blood cultures were
taken, which yielded no growth. On day 20 of hospitalisation
Staphylococcus epidermidis was isolated from two of two blood
cultures (blood culture results from day 20–42 are listed in Table 1).
The isolates were methicillin resistant and susceptible to vanco-
mycin and teicoplanin. Treatment with vancomycin 1 g b.i.d. was
started, adjusted to renal insufficiency. In addition, an antibiotic-
lock (with vancomycin 1000 g/ml in liquemin) was infused into
the central venous catheter in an attempt to save it. A normal
colony form and an SCV of Staphylococcus epidermidis were
isolated from a blood culture taken 11 h after the start of
vancomycin therapy. Both colony forms were methicillin resistant
and vancomycin sensitive. While the normal form was teicoplanin
sensitive, the SCV was teicoplanin resistant. A blood culture taken
24 h after the start of antibiotic therapy yielded no bacterial growth
but Staphylococcus epidermidis was again isolated from a blood
culture of the following day. Three days after the initiation of
vancomycin therapy the central-venous catheter was replaced.
Cultures of the catheter tip yielded no growth. On day 31 of
hospitalisation amikacin was added to the treatment regimen.
Despite adequate therapy, the patient continued to be septic and
both colony forms of Staphylococcus epidermidis were isolated
from several blood cultures. The central venous catheter was
removed on day 35 of hospitalisation. No bacteria could be cultured
from the catheter. On day 38, rifampicin was added to the treatment
regimen. Ultrasound examination excluded the presence of septic
thrombophlebitis. Transesophageal echocardiography did not show
any evidence of endocarditis. Life support was suspended because
the patient did not recover from neutropenia and fungal pneumonia
was suspected. High-dose corticosteroid therapy was added to the
regimen to control continuous febrile episodes with shivering. The
patient died on day 20 after the start of antimicrobial treatment as a
result of non-responding clinical sepsis. Autopsy results confirmed
there was no evidence of endocarditis or septic thrombophlebitis.
Histologic examination revealed multiple nodes with fungal
elements compatible with aspergillosis in the lower right lobe of
the lung. However, no fungi grew in cultures from lung tissue,
presumably due to the antifungal therapy.
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Materials and Methods
Blood cultures were processed with an automated system (BacT/
ALERT; bioMrieux, USA). Aliquots of the broth were subcultured
on Columbia agar with 5% sheep blood and incubated at 37C in
5% CO2 and under anaerobic conditions for 48 h. Intravenous
catheter tips were cultured as described by Maki et al. [7]. The
clinical isolates of Staphylococcus epidermidis were identified
based on their biochemical profile with the API Staph Kit
(bioMrieux, France). Identification was confirmed using the
MicroSeq 16S rRNA gene kit (Applied Biosystems, USA). The
amplified DNA was sequenced on an automated DNA sequencer
(ABI PRISM 310 Sequencer, Applied Biosystems). Molecular
typing was performed by pulsed-field gel electrophoresis (PFGE) as
previously described [8], genomic DNA being digested by the
restriction endonuclease SmaI. Susceptibility testing was performed
according to NCCLS guidelines [9] by broth microdilution using
commercially manufactured plates (Micronaut-S; Merlin Diagnos-
tics, Germany). Resistance to methicillin was confirmed by
detection of penicillin-binding protein 2’ (MRSA-Screen; Denka
Seiken, Japan) after induction with oxacillin [10]. MICs of
teicoplanin and vancomycin were confirmed by the E test (AB-
Biodisk, Sweden), applying an inoculum of 0.5 McFarland on
Mueller Hinton agar with 5% sheep blood. In addition, isolates
were screened for hetero-resistance to vancomycin using the
vancomycin E test with an inoculum of 2.0 McFarland on brain
heart infusion agar [11].
Results and Discussion
The normal colonies of Staphylococcus epidermidis were
found after overnight incubation of subculture plates.
SCVs were usually detected after 24–72 h of incubation.
Their colony diameter was around 1 mm. SCVs showed a
tendency to revert to the normal form upon further
subculturing and we were not able to conserve the small
colony phenotype over prolonged periods of time. Both
colony forms were identified as Staphylococcus epider-
midis. Sequence analysis of a 500-bp fragment of the
rRNA gene showed 100% homology with the type strain.
PFGE restriction fragment patterns of normal colony form
and of the SCVs were indistinguishable. All isolates of
Staphylococcus epidermidis (normal form and SCVs)
were resistant to methicillin, tobramycin, cotrimoxazole,
ciprofloxacin and levofloxacin and sensitive to netilmicin.
They were uniformly susceptible to vancomycin (MIC
3 mg/l) and there was no evidence of vancomycin hetero-
resistance. While the normal colony forms were suscep-
tible to teicoplanin (MIC 1 mg/l), all but one of the
isolates of SCVs were teicoplanin resistant (MIC 24 mg/l).
SCVs of Staphylococcus aureus have been reported to
cause persistent and recurrent infections [1, 2, 3].
Compared with their normal phenotypes, they often show
reduced susceptibilities to several antimicrobial agents,
namely aminoglycosides and cotrimoxazole [3, 12]. In the
few reported cases of infection with SCVs of CoNS [4, 5,
6] such differences between the two colony forms were
not observed. Here we describe the first case of an
infection with a teicoplanin-resistant staphylococcal SCV.
The patient was treated with vancomycin including
vancomycin-lock for suspected bloodstream infection
after methicillin-resistant Staphylococcus epidermidis
had been isolated from two blood cultures. A normal
colony form and an SCV of Staphylococcus epidermidis
were recovered from a blood culture performed 11 h after
the start of vancomycin therapy. In contrast to the normal
phenotype, the SCV was resistant to teicoplanin. Both
Table 1 Blood culture results
from days 20–42 of hospital-
ization
Day of
hospital-
isation
Blood
culture
no.
Isolation of S. epidermidis Remarks
Large colonies SCVs
20 16 +, teicoplanin S 
17 +, teicoplanin S 
21 18 +, teicoplanin S 
22 19 +, teicoplanin S  start of vancomycin therapy
20 +, teicoplanin S +, teicoplanin R
23 21  
24 22 +, teicoplanin S 
25 23   replacement of catheter
24 +, teicoplanin S 
26 25 +, teicoplanin S +, teicoplanin S
27 26 +, teicoplanin S +, teicoplanin R
28 27 +, teicoplanin S +, teicoplanin R
29 28 +, teicoplanin S 
30 29 +, teicoplanin S 
31 30 +, teicoplanin S +, teicoplanin R addition of amikacin to therapy
35 31 +, teicoplanin S +, teicoplanin R replacement of catheter
32 +, teicoplanin S 
33 +, teicoplanin S 
37 34 +, teicoplanin S 
35 +, teicoplanin S 
38 addtion of rifampicin to therapy
39 36  
40 37 +, teicoplanin S 
41 38 +, teicoplanin S 
39  
42 40   patient died
+, growth; , no growth; S, susceptible; R, resistant
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phenotypes were susceptible to vancomycin. Identical
PFGE patterns showed both forms to be clonal.
Two scenarios exist for the occurrence of the tei-
coplanin-resistant SCV. Firstly, resistance to teicoplanin
developed during exposure to the high concentration of
vancomycin associated with vancomycin-lock. Similarly,
SCVs isolated from patients after local treatment for
osteomyelitis with gentamicin beads had up to 32-fold
higher MICs of gentamicin than the parent strain (1 mg/ml
vs. <0.031 mg/ml) [2]. It is remarkable that resistance to
teicoplanin, but not to vancomycin, may have evolved
under vancomycin therapy. Even though development of
vancomycin-resistant SCVs of Staphylococcus haemolyti-
cus after exposure to vancomycin has been reported [13],
resistance to teicoplanin might still be easier to obtain
under selective pressure from vancomycin than resistance
to vancomycin itself. Cercenado et al. [14] found CoNS
with reduced susceptibilities to teicoplanin but full
susceptibility to vancomycin in 32 patients, eight of
whom had been treated with vancomycin. Secondly,
taking into account the tendency of SCVs to revert to the
normal form, we cannot exclude the possibility that they
developed spontaneously before vancomycin therapy but
were missed in the corresponding blood cultures. Emer-
gence of a teicoplanin-resistant SCV of Staphylococcus
aureus during experimental foreign body infection in a rat
without antibiotic therapy has been reported [15]. How-
ever, this is the first report of the emergence of a
teicoplanin-resistant SCV of a Staphylococcus species in
a patient.
Based on the following evidence, it is conceivable that
persistence of the bloodstream infection was caused by
the development of the SCV. (i) Antibiotic therapy was
performed according to established treatment guidelines
and susceptibility testing. (ii) The central-venous line was
promptly removed once persistent bacteremia was ob-
served, whereas bacteria could not be cultured from the
catheter. A new catheter was inserted at a different
location. (iii) Neither doppler ultrasound of the subclavian
vein and transesophageal echocardiography nor the
autopsy showed any evidence of septic thrombophlebitis
or endocarditis. Treatment failure despite adequate anti-
biotic therapy has been reported in four patients with
osteomyelitis due to SCVs of Staphylococcus aureus [2]
and in a patient with pacemaker-associated vegetations
due to SCVs of Staphylococcus capitis [6]. SCVs of
Staphylococcus epidermidis were also isolated in a fatal
case of prosthetic heart valve endocarditis [4].
Between the start of vancomycin therapy and the death
of the patient, both colony forms were isolated from six
blood cultures while ten blood cultures yielded solely the
normal form. Taking into account its tendency to revert,
we believe that Staphylococcus epidermidis survived as
SCV and reverted to the normal form upon cultivation.
Because of both their tendency to revert and their slow
growth, SCVs of staphylococci may easily go undetected.
Thus, the number of cultures should be increased and
incubation of subcultures should be extended if infection
with SCVs of staphylococci is suspected.
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